Further Fertility Preservation Techniques View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2020-07-01

AUTHORS

Ralf Dittrich , Michael von Wolff

ABSTRACT

Cryopreservation of oocytes and ovarian tissue as well as the administration of GnRH agonists and transposition of the ovaries are well established as fertility preservation methods. In addition, there are alternative techniques that are less well established or still experimental. These techniques include medication to protect the ovaries, such as AS101, CIP and AMH, measures to use the ovarian tissue in patients with leukaemia and other diseases with a high risk of malignant cells in the ovarian tissue such as xenotransplantation, IVG and artificial ovaries, stem cells and uterus transplantation. More... »

PAGES

241-250

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_27

DOI

http://dx.doi.org/10.1007/978-3-030-47568-0_27

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1128875870


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1114", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Paediatrics and Reproductive Medicine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University Hospital Erlangen, OB/GYN, Friedrich-Alexander University Erlangen-N\u00fcrnberg (FAU), Erlangen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411668.c", 
          "name": [
            "University Hospital Erlangen, OB/GYN, Friedrich-Alexander University Erlangen-N\u00fcrnberg (FAU), Erlangen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dittrich", 
        "givenName": "Ralf", 
        "id": "sg:person.01314234440.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314234440.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gynaecological Endocrinology and Reproductive Medicine, University Women\u2019s Hospital, University of Bern, Bern, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.5734.5", 
          "name": [
            "Division of Gynaecological Endocrinology and Reproductive Medicine, University Women\u2019s Hospital, University of Bern, Bern, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "von Wolff", 
        "givenName": "Michael", 
        "id": "sg:person.0610777233.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610777233.66"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2020-07-01", 
    "datePublishedReg": "2020-07-01", 
    "description": "Cryopreservation of oocytes and ovarian tissue as well as the administration of GnRH agonists and transposition of the ovaries are well established as fertility preservation methods. In addition, there are alternative techniques that are less well established or still experimental. These techniques include medication to protect the ovaries, such as AS101, CIP and AMH, measures to use the ovarian tissue in patients with leukaemia and other diseases with a high risk of malignant cells in the ovarian tissue such as xenotransplantation, IVG and artificial ovaries, stem cells and uterus transplantation.", 
    "editor": [
      {
        "familyName": "von Wolff", 
        "givenName": "Michael", 
        "type": "Person"
      }, 
      {
        "familyName": "Nawroth", 
        "givenName": "Frank", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-030-47568-0_27", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-030-47567-3", 
        "978-3-030-47568-0"
      ], 
      "name": "Fertility Preservation in Oncological and Non-Oncological Diseases", 
      "type": "Book"
    }, 
    "keywords": [
      "ovarian tissue", 
      "fertility preservation methods", 
      "fertility preservation techniques", 
      "cryopreservation of oocytes", 
      "GnRH agonist", 
      "uterus transplantation", 
      "artificial ovary", 
      "high risk", 
      "malignant cells", 
      "ovaries", 
      "stem cells", 
      "tissue", 
      "preservation techniques", 
      "medications", 
      "cells", 
      "AS101", 
      "patients", 
      "transplantation", 
      "agonists", 
      "leukemia", 
      "xenotransplantation", 
      "disease", 
      "administration", 
      "AMH", 
      "alternative technique", 
      "risk", 
      "oocytes", 
      "preservation methods", 
      "cryopreservation", 
      "transposition", 
      "IVG", 
      "measures", 
      "technique", 
      "addition", 
      "CIP", 
      "method"
    ], 
    "name": "Further Fertility Preservation Techniques", 
    "pagination": "241-250", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1128875870"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-030-47568-0_27"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-030-47568-0_27", 
      "https://app.dimensions.ai/details/publication/pub.1128875870"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-09-02T16:11", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/chapter/chapter_191.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-030-47568-0_27"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_27'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_27'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_27'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_27'


 

This table displays all metadata directly associated to this object as RDF triples.

110 TRIPLES      22 PREDICATES      60 URIs      53 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-030-47568-0_27 schema:about anzsrc-for:11
2 anzsrc-for:1114
3 schema:author Ne3acc628a6c74777a73cd9b1f41bd12b
4 schema:datePublished 2020-07-01
5 schema:datePublishedReg 2020-07-01
6 schema:description Cryopreservation of oocytes and ovarian tissue as well as the administration of GnRH agonists and transposition of the ovaries are well established as fertility preservation methods. In addition, there are alternative techniques that are less well established or still experimental. These techniques include medication to protect the ovaries, such as AS101, CIP and AMH, measures to use the ovarian tissue in patients with leukaemia and other diseases with a high risk of malignant cells in the ovarian tissue such as xenotransplantation, IVG and artificial ovaries, stem cells and uterus transplantation.
7 schema:editor Nb23f848ca27e4029926e4211953ae73b
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N8d9e2dfc93bd4397823a0cc73b363605
11 schema:keywords AMH
12 AS101
13 CIP
14 GnRH agonist
15 IVG
16 addition
17 administration
18 agonists
19 alternative technique
20 artificial ovary
21 cells
22 cryopreservation
23 cryopreservation of oocytes
24 disease
25 fertility preservation methods
26 fertility preservation techniques
27 high risk
28 leukemia
29 malignant cells
30 measures
31 medications
32 method
33 oocytes
34 ovarian tissue
35 ovaries
36 patients
37 preservation methods
38 preservation techniques
39 risk
40 stem cells
41 technique
42 tissue
43 transplantation
44 transposition
45 uterus transplantation
46 xenotransplantation
47 schema:name Further Fertility Preservation Techniques
48 schema:pagination 241-250
49 schema:productId N9defa8ea23374b1689fabe8e85948978
50 Ne369833edf734e90b3038dc96d12451d
51 schema:publisher N1e925aec871742e88dbe1c7525c27256
52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1128875870
53 https://doi.org/10.1007/978-3-030-47568-0_27
54 schema:sdDatePublished 2022-09-02T16:11
55 schema:sdLicense https://scigraph.springernature.com/explorer/license/
56 schema:sdPublisher Nc9fefaa1525a420d90d2455fa43a0a42
57 schema:url https://doi.org/10.1007/978-3-030-47568-0_27
58 sgo:license sg:explorer/license/
59 sgo:sdDataset chapters
60 rdf:type schema:Chapter
61 N1e925aec871742e88dbe1c7525c27256 schema:name Springer Nature
62 rdf:type schema:Organisation
63 N2c46a7d787cd42018b1ff827b76857ba rdf:first N3691b39df34c4c92b6297e829a8e0b61
64 rdf:rest rdf:nil
65 N3691b39df34c4c92b6297e829a8e0b61 schema:familyName Nawroth
66 schema:givenName Frank
67 rdf:type schema:Person
68 N8d9e2dfc93bd4397823a0cc73b363605 schema:isbn 978-3-030-47567-3
69 978-3-030-47568-0
70 schema:name Fertility Preservation in Oncological and Non-Oncological Diseases
71 rdf:type schema:Book
72 N9a7a6a1172f14ba48281b1d3d7470137 rdf:first sg:person.0610777233.66
73 rdf:rest rdf:nil
74 N9defa8ea23374b1689fabe8e85948978 schema:name dimensions_id
75 schema:value pub.1128875870
76 rdf:type schema:PropertyValue
77 Nb23f848ca27e4029926e4211953ae73b rdf:first Nbfbf964bc82140d1bb092fadc78e876d
78 rdf:rest N2c46a7d787cd42018b1ff827b76857ba
79 Nbfbf964bc82140d1bb092fadc78e876d schema:familyName von Wolff
80 schema:givenName Michael
81 rdf:type schema:Person
82 Nc9fefaa1525a420d90d2455fa43a0a42 schema:name Springer Nature - SN SciGraph project
83 rdf:type schema:Organization
84 Ne369833edf734e90b3038dc96d12451d schema:name doi
85 schema:value 10.1007/978-3-030-47568-0_27
86 rdf:type schema:PropertyValue
87 Ne3acc628a6c74777a73cd9b1f41bd12b rdf:first sg:person.01314234440.77
88 rdf:rest N9a7a6a1172f14ba48281b1d3d7470137
89 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
90 schema:name Medical and Health Sciences
91 rdf:type schema:DefinedTerm
92 anzsrc-for:1114 schema:inDefinedTermSet anzsrc-for:
93 schema:name Paediatrics and Reproductive Medicine
94 rdf:type schema:DefinedTerm
95 sg:person.01314234440.77 schema:affiliation grid-institutes:grid.411668.c
96 schema:familyName Dittrich
97 schema:givenName Ralf
98 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314234440.77
99 rdf:type schema:Person
100 sg:person.0610777233.66 schema:affiliation grid-institutes:grid.5734.5
101 schema:familyName von Wolff
102 schema:givenName Michael
103 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610777233.66
104 rdf:type schema:Person
105 grid-institutes:grid.411668.c schema:alternateName University Hospital Erlangen, OB/GYN, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
106 schema:name University Hospital Erlangen, OB/GYN, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
107 rdf:type schema:Organization
108 grid-institutes:grid.5734.5 schema:alternateName Division of Gynaecological Endocrinology and Reproductive Medicine, University Women’s Hospital, University of Bern, Bern, Switzerland
109 schema:name Division of Gynaecological Endocrinology and Reproductive Medicine, University Women’s Hospital, University of Bern, Bern, Switzerland
110 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...